ALISON FLYNN: Open Payments
NPI 1174937197 · PITTSFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 11 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $39 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $153 |
| Lilly USA, LLC | 1 | $94 |
| Novo Nordisk Inc | 2 | $48 |
| GlaxoSmithKline, LLC. | 1 | $27 |
Products named: INGREZZA, KISUNLA, Ozempic, AREXVY.
Industry payments across MA — which companies pay providers there.
